| 000 | 01613 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514052443.0 | ||
| 264 | 0 | _c20030404 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0031-6970 | ||
| 024 | 7 |
_a10.1007/s00228-002-0512-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBapiro, Tashinga E | |
| 245 | 0 | 0 |
_aCytochrome P450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _cNov 2002 |
||
| 300 |
_a537-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlbendazole _xpharmacology |
| 650 | 0 | 4 |
_aAntiparasitic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP1A1 _xbiosynthesis |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP1A2 _xbiosynthesis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEnzyme Induction |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPolychlorinated Dibenzodioxins _xmetabolism |
| 650 | 0 | 4 |
_aPrimaquine _xpharmacology |
| 650 | 0 | 4 |
_aQuinine _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aAndersson, Tommy B | |
| 700 | 1 | _aOtter, Charlotta | |
| 700 | 1 | _aHasler, Julia A | |
| 700 | 1 | _aMasimirembwa, Collen M | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 58 _gno. 8 _gp. 537-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00228-002-0512-z _zAvailable from publisher's website |
| 999 |
_c12257662 _d12257662 |
||